overview:
  # viral family: one of ['coronaviridae', 'flaviviridae', 'picornaviridae', 'togaviridae']
  family: coronaviridae
  name: "SARS-CoV-2 / MERS-CoV Mpro protease"
  target: Mpro
  program_code: ASAPPTGTTM
  program_nickname: ASAP-COV-MPRO
  viruses:
    - MERS-CoV
    - SARS-CoV-2
  img: "SARS-CoV-2 Mpro.png"

funding_source:  
  funder: National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)
  grant: U19AI171399
  img: niaid-logo.png
  url: https://reporter.nih.gov/search/EpbjKrq7Kki8EBHx4eMWbw/project-details/10513865

targeting_opportunity:
  status: completed
  url: https://asapdiscovery.notion.site/Targeting-Opportunity-SARS-CoV-2-MERS-CoV-Mpro-warm-start-a8457fb68f794b398b5f902429917dd4
  events:
    - date: 2023-03-19
      description: Initial draft

DMS:
  # 'status' controls the status box rendered for this stage
  status: completed
  url: https://jbloomlab.github.io/SARS2-mut-fitness/nsp5.html
  products:
  # This paper is citeable
  - name: Analysis of circulating variants of SARS-CoV-2 Mpro (nsp5)
    date-completed: 2023-01-31
    url: https://jbloomlab.github.io/SARS2-mut-fitness/nsp5.html
    preprint: https://www.biorxiv.org/content/10.1101/2023.01.30.526314v1
    RPPR: [P1]
    events:
      - date: 2023-01-31
        description: A preprint was posted to bioRxiv.
      - date: 2023-01-31
        description: A public website was posted.
    links:
      - action: Download simulation scripts
        short: GitHub
        description: Scripts for structure preparation, docking, and simulation of MEN1 mutants interacting with inhibitors
        url: https://github.com/choderalab/men1
      - action: Download the datasets
        short: OSF
        description: Data from free energy calculations, Folding@home trajectories, and Markov state models of MEN1 mutants
        url: https://osf.io/uge5j/
  # NOTE: This paper is not citeable by the RPPR, but we will be able to cite it if we reformat it as an interactive website
  - name: Deep mutational scanning of SARS-CoV-2 Mpro
    url: https://elifesciences.org/articles/77433    
    doi: 10.7554/eLife.77433
    RPPR: []
    events:
      - date: 2022-07-26
        description: Published in eLife.    
  
TPP:
  status: completed
  id: ASAP-TPP-MERS-CoV-SARS-CoV-2

TCP:
  status: completed
  id: ASAP-TCP-COV-MPRO

assay_cascade:
  status: completed
  id: ASAP-ASSAY-COV-MPRO

TEP:
  # TODO: Can we pull the status rom the TEP itself?
  status: in-progress

hit_to_lead:
  status: completed

covalent_targeting:
  status: in-progress
  #url: https://covid.postera.ai/covid/activity_data
  
lead_optimization:
  status: in-progress

molecules:
  releases:
  - name: "SARS-CoV-2/MERS-CoV Mpro lead optimization biochemical assay - negative data"
    metadata: https://www.notion.so/asapdiscovery/SARS-CoV-2-and-MERS-Main-Protease-Mpro-Fluorescence-Dose-Response-Data-a23b21fe8fce4e1494c4c6720b072c1e
    data: https://app.postera.ai/account/molecule-set/cf233d08-520b-4934-a647-932d7b8b2a06
    project: "Project 5"
    core: "Biochemical Assay Core"
    description: |
        This data release contains assay data for compounds ASAP is not pursuing toward nomination of a development candidate as part of this discovery program.
